Eculizumab for paediatric patients with atypical haemolytic-uremic syndrome: full dataset analysis of post-marketing surveillance in Japan.

Shuichi ItoHiroshi HatayaAkira AshidaRiku HamadaTomoaki IshikawaYumiko IshikawaAkihiko ShimonoTakao KonomotoTomoki MiyazawaMasao OguraKazuki TanakaShoji Kagami

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

Eculizumab was well tolerated and effective for paediatric patients with aHUS in the real-world setting in Japan.

Keyphrases

intensive care unit
emergency department
public health
case report